MedTrace Logo

Fentanyl Use for Sedation in Esophagogastroduodenoscopy

NCT01514695 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2013-01-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether conscious sedation with a narcotic and sedative (in combination) is as efficacious as a sedative alone for elective upper endoscopy to achieve optimal patient comfort and ease of procedure.

Conditions

  • Endoscopy

Interventions

DRUG

Midazolam

Starting with 1mg intravenously in all patients. More can be added at the discretion of the physician as needed for sedation.

DRUG

Fentanyl

100mcg intravenously given in 2mL syringe at start of procedure

OTHER

Placebo

One dose of saline (2ml)

Sponsors & Collaborators

Principal Investigators

  • Khurram J Khan, MD, BSc, MSc · St Joseph's Healthcare Hamilton, McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01514695 on ClinicalTrials.gov